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2463In contrast, large voltages did not differentiate the
2 populations (15.3% of athletes vs. 12.9% of HCM;
p ¼ 0.35). Early repolarization with ST-segment
elevation >0.1 mV in V2 was too common in athletes
(33.7%) to serve as a helpful marker.
Characteristics that best differentiated the 2 pop-
ulations as described previously were designated
minor ECG criteria and assigned 1 point, whereas
characteristics not present in any athlete were des-
ignated major ECG criteria and assigned 2 points.
Major ECG criteria included T-wave inversions deeper
than 0.5 mV, ST-segment depressions deeper than
0.1 mV, and left bundle branch block. The ﬁnal list of
optimal HCM ECG characteristics, their frequencies,
and examples of each abnormality are presented in
Table 1. Many of the characteristics contributed
independently on multivariate analysis.
Using the optimal ECG characteristic scores, 4.0%
of athletes and 72.2% of all HCM patients received 1 or
more points, while 47.1% of all HCM patients and only
1 athlete (0.09%) received 2 or more points. A score of
1 (1 minor ECG abnormality) distinguished HCM pa-
tients from athletes with 72% sensitivity and 96%
speciﬁcity; while a score of 2 (1 major or 2 minor ECG
abnormalities) distinguished the 2 groups with 47%
sensitivity, 99.9% speciﬁcity, and a false positive rate
of <1 of 1,000.
Although these ﬁndings need validation, ideally
using a young athletic HCM cohort, we have identiﬁed
criteria that result in a low false positive and maintain
reasonable sensitivity, which we believe supports the
use of the digital 12-lead ECG in athletic screening.Rachel E. Bent
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Weight Change on
Cardiac Remodeling
Over 20 Years
The CARDIA (Coronary Artery Risk
Development in Young Adults) StudyRelative weight, often characterized as body mass
index (BMI), is a factor associated with left ventricu-
lar (LV) mass and geometry. Cross-sectional studies in
middle-aged adults showed higher BMI was associ-
ated with higher LV mass and volumes (1). Longitu-
dinal data in another middle-aged cohort showed
higher initial BMI was associated with greater in-
crease in LV mass (2).
The goal of this study was to determine whether
BMI was associated with changing cardiac structure
and function over the next 20 years and whether
maintaining a stable BMI was associated with less
change in cardiac structure and function.
The CARDIA (Coronary Artery Risk Development in
Young Adults Study) study recruited 5,115 Caucasian
and African American men and women, 18 to 30 years
of age, in 4 U.S. centers in 1985 (year 1). We stratiﬁed
participants by year 5 (initial) BMI (kg/m2): 18.5 to
24.9, 25 to 29.9, 30 to 34.9, $35. We further stratiﬁed
participants by BMI change between years 5 and 25:
increasing BMI (>2), stable BMI (#2), and ﬂuctuating
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Blind rereading of echocardiograms to assess inter-
reader variability, intrareader variability, and intra-
patient variability showed LV mass coefﬁcients
of variability were <8% (3). LV mass index (LVMi) ¼
LV mass/height1.7. Year 25 minus year 5 differences
in risk factor-adjusted (age, sex, race, systolic
blood pressure, antihypertensive use, heart rate, low-
density lipoprotein cholesterol, high-density lipo-
protein cholesterol, diabetes, tobacco and alcohol
use) echocardiographic variables were examined us-
ing an analysis of covariance, treating initial (year 5)
BMI group and BMI change group as the main effects.
At year 5, the LVMi cohort was 51% white and 45%
male with mean age of 30 years. There was no inter-
action between initial BMI and BMI change. Initial
BMI was associated with change in LVMi (p ¼ 0.02)
and left ventricular ejection fraction (LVEF)
(p ¼ 0.009). BMI change was associated with change
in LVMi (p < 0.0001), relative wall thickness (RWT)
(p ¼ 0.006), and LV end-diastolic volume index
(LVEDVi) (p < 0.0001). Table 1 displays changes in
LVMi and LVEF. RWT only changed in participants
with increasing BMI (0.011  0.003; p ¼ 0.0005).
LVEDVi only changed in participants with increasing
(–10  1 ml/m2; p < 0.0001) and ﬂuctuating
(–12  2 ml/m2; p < 0.0001) BMI. In the increasing BMI
group, for each adjusted 1 kg/m2 increase in BMI,
LVMi increased 0.9  0.1 g/m1.7 (p < 0.0001) and
LVEDVi decreased –0.4  0.2 ml/m2 (p ¼ 0.02).
Higher initial BMI was associated with greater in-
crease in LVMi, which is consistent with previous
studies (2). We showed the novel ﬁnding that BMI
stability over 20 years was associated with increasedTABLE 1 Twenty-Year Risk Factor Adjusted Change in Left Ventricula
Stable BMI Fluctuating BM
Left Ventricular Mass Ind
18.5–24.9 3.9  1.1 (0.0007)* 4.1  1.6 (0.01)‡
25–29.9 4.0  1.9 (0.03)† 8.7  1.9 (<0.00
30–34.9 11.1  3.1 (0.003) 6.1  3.1 (0.05)‡
35þ 7.8  3.5 (0.02) 5.1  3.7 (0.17)‡
Pooled initial BMI 6.7  1.3 (<0.0001)* 6.0  1.3 (<0.00
Left Ventricular Ejection F
18.5–24.9 –1  1 (0.05) –2  1 (0.04)
25–29.9 –1  1 (0.43) 1  1 (0.61)
30–34.9 –1  2 (0.58) –1  3 (0.59)
35þ –7  3 (0.04) –10  4 (0.00
Pooled initial BMI –3  1 (0.01) –3  1 (0.01)
Values are mean change  SE (p value comparing year 5 to year 25). Stable/ﬂuctuating
†p # 0.001. ‡p < 0.05.LVMi. Long-term exposure to pathologic changes of
obesity, without further weight gain may be sufﬁcient
to cause this increase. As a result, BMI stability may
not be an adequate goal for overweight individuals.
Fluctuating BMI was associated with a lower increase
in LVMi than increasing BMI, suggesting transient
increases in BMI may not be as harmful as long as the
individual eventually loses weight.
The current study supports the idea that obesity
increases wall thickness more than it increases cavity
size. We found increasing BMI was associated with
concentric remodeling (LVMi and RWT increased).
However, we also showed the novel ﬁnding that
stable and ﬂuctuating BMI were associated with
eccentric remodeling (LVMi increased but RWT
did not). This may reconcile how obesity was
previously believed to be associated with eccentric
remodeling.
We showed the novel ﬁnding that higher initial
BMI was associated with greater decrease in LVEF
over 20 years. Compensatory cardiac remodeling may
maintain LVEF in the short term, as seen in cross-
sectional studies, but cannot do so in the setting of
persistently elevated BMI over the long term follow-
up conducted in this study.
In summary, in this prospective, longitudinal study
of young adults, we showed that both higher initial
BMI and increases in BMI were associated with
adverse changes over 20 years in LV structure and
function. Even participants with stable but high BMI
developed adverse LV change. These observations
support the need to maintain lower BMI from an early
age to prevent adverse LV remodeling over time and
eventual decrease in LVEF.r Mass Index and Left Ventricular Ejection Fraction
I Increased BMI BMI Change Groups Pooled
ex (n ¼ 2,263), g/m1.7
9.1  0.6 (<0.0001) 5.7  0.7 (<0.0001)
01) 10.8  0.8 (<0.0001) 7.9  0.9 (<0.0001)
14.8  1.4 (<0.0001) 10.7  1.5 (<0.0001)
14.3  2.0 (<0.0001) 9.0  1.8 (<0.0001)
01)* 12.2  0.7 (<0.0001)
raction (n ¼ 1,143), %
–1  0.4 (0.01) –2  0.5 (0.0007)
‡ –2  1 (0.001) –1  1 (0.21)
–2  1 (0.05) –2  1 (0.18)
9) –5  2 (0.006) –7  2 (<0.001)
–3  1 (<0.001)
body mass index (BMI) groups are compared to increasing BMI groups: *p # 0.0001.
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An Illusion or a True Key to Successful
Ablation of Atrial Fibrillation?We read with great interest the article by Kottkamp
et al. (1). We agree that atrial ﬁbrosis may play an
important role in the maintenance of atrial ﬁbrillation
(AF). However, we would like to stress a few points
that seem to us important.
First, causal relationship between atrial ﬁbrosis
and AF has not been clearly conﬁrmed. In fact, recent
evidence indicates that while the atrial ﬁbrosis
naturally accompanies structural heart disease it is
not directly linked to AF per se (2). There is also no
direct evidence that AF can promote atrial ﬁbrosis in
humans. Clearly, the pathophysiology of AF extends
far beyond the mere concept of atrial ﬁbrosis.
Second, although magnetic resonance imaging
with late gadolinium enhancement (LGE) has been
extensively validated for visualization of a distinct
post-infarction scar in the left ventricle, thetechnique has not been histologically validated for
detection of predominantly diffuse pre-ablation
ﬁbrosis in the atria by any systematic study in
humans or in an animal experiment. Similarly, there
is no histological proof that low endocardial voltage
in the atria reﬂects solely ﬁbrosis. Therefore, we
believe that neither low endocardial voltage nor the
LGE may be interpreted as atrial ﬁbrosis without
precautious.
Our own data show no correlation between the
extent of pre-ablation left atrial LGE and other
characteristics of the atrial remodeling such as
volume, phasic function, or bipolar voltage. Most
importantly, in our experience the extent of left
atrial LGE does not predict AF recurrence after
ablation (3).
Thus, we feel that more solid experimental and
clinical evidence is needed before clinical application
of the proposed approaches to ablation of AF that are
based on visualization and modiﬁcation of the pre-
sumed “atrial ﬁbrosis.”*Marek Sramko, MD, PhD
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An Illusion or a True Key to Successful Ablation of
Atrial Fibrillation?We thank Drs. Sramko and Kautzner for their interest
in our manuscript (1). The success rates of current
stepwise ablation approaches adding the placement
